Light-driven heterogeneous reduction of carbon dioxide: photocatalysts and photoelectrodes
…, JE Pander III, Y Hu, IC Fortmeyer, JE Park… - Chemical …, 2015 - ACS Publications
Light-Driven Heterogeneous Reduction of Carbon Dioxide: Photocatalysts and Photoelectrodes
| Chemical Reviews ACS ACS Publications C&EN CAS Find my institution Blank image Log In …
| Chemical Reviews ACS ACS Publications C&EN CAS Find my institution Blank image Log In …
The role of endothelin-1 in the pathogenesis of pulmonary arterial hypertension
D Shao, JES Park, SJ Wort - Pharmacological Research, 2011 - Elsevier
The term pulmonary arterial hypertension (PAH) describes a rare group of diseases
characterized by raised pulmonary vascular resistance, resulting from vascular remodelling in the …
characterized by raised pulmonary vascular resistance, resulting from vascular remodelling in the …
A submicrodetemination of glucose.
JT Park, MJ Johnson - Journal of Biological Chemistry, 1949 - cabdirect.org
The method described is a sensitive colorimetric method based on the reduction of ferricyande
followed by the formation of Prussian blue, which is measured photo-electrically at 650 to …
followed by the formation of Prussian blue, which is measured photo-electrically at 650 to …
[HTML][HTML] Histamine and skin barrier: are histamine antagonists useful for the prevention or treatment of atopic dermatitis?
A De Benedetto, T Yoshida, S Fridy, JES Park… - Journal of clinical …, 2015 - mdpi.com
Atopic Dermatitis (AD), the most common chronic inflammatory skin disease, is characterized
by an overactive immune response to a host of environmental allergens and dry, itchy skin. …
by an overactive immune response to a host of environmental allergens and dry, itchy skin. …
[HTML][HTML] Multi-cancer early detection test in symptomatic patients referred for cancer investigation in England and Wales (SYMPLIFY): a large-scale, observational …
…, PS Virdee, DA Harris, C O'Doherty, JES Park… - The Lancet …, 2023 - thelancet.com
Background Analysis of circulating tumour DNA could stratify cancer risk in symptomatic
patients. We aimed to evaluate the performance of a methylation-based multicancer early …
patients. We aimed to evaluate the performance of a methylation-based multicancer early …
Overview of the fundamental reactions and degradation mechanisms of NOx storage/reduction catalysts
…, LE Campbell, A Yezerets, NW Currier, JE Parks - Catalysis …, 2004 - Taylor & Francis
Over the last several years, nitrogen oxide(s) (NOx) storage/reduction (NSR) catalysts, also
referred to as NOx adsorbers or lean NOx traps, have been developed as an aftertreatment …
referred to as NOx adsorbers or lean NOx traps, have been developed as an aftertreatment …
NCCN guidelines® Insights: biliary tract cancers, version 2.2023: featured updates to the NCCN guidelines
…, RK Kelley, R Kim, M Levine, M Palta, JO Park… - Journal of the National …, 2023 - jnccn.org
In 2023, the NCCN Guidelines for Hepatobiliary Cancers were divided into 2 separate guidelines:
Hepatocellular Carcinoma and Biliary Tract Cancers. The NCCN Guidelines for Biliary …
Hepatocellular Carcinoma and Biliary Tract Cancers. The NCCN Guidelines for Biliary …
The HRCT appearances of granulomatous pulmonary disease in common variable immune deficiency
JES Park, I Beal, JP Dilworth, V Tormey… - European journal of …, 2005 - Elsevier
Approximately 10% of patients with common variable immune deficiency have systemic
granulomatous disease with associated interstitial lung disease. From a population of patients …
granulomatous disease with associated interstitial lung disease. From a population of patients …
[HTML][HTML] Intrahepatic microbes govern liver immunity by programming NKT cells
The gut microbiome shapes local and systemic immunity. The liver is presumed to be a protected
sterile site. As such, a hepatic microbiome has not been examined. Here, we showed a …
sterile site. As such, a hepatic microbiome has not been examined. Here, we showed a …
[HTML][HTML] Safety and efficacy of vebicorvir administered with entecavir in treatment-naïve patients with chronic hepatitis B virus infection
…, HWL Hann, DT Dieterich, RG Nahass, JS Park… - Journal of …, 2022 - Elsevier
Background & Aims Nucleos(t)ide reverse transcriptase inhibitors do not completely suppress
HBV DNA in chronic HBV infection (cHBV). Vebicorvir (VBR) is an investigational core …
HBV DNA in chronic HBV infection (cHBV). Vebicorvir (VBR) is an investigational core …